Chi Young

1.1k citations

20 papers · 289 indexed · h-index 7

Impact in

Immunology
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Oncology
- CAR-T cell therapy research

Papers in ⓘ

Immunology 10
- Phagocytosis and Immune Regulation 3
- Immune Cell Function and Interaction 3
- Immune Response and Inflammation 3
Oncology 9
- CAR-T cell therapy research 6

Co-authors: Sonja Schrepfer (9 shared papers)T. Deuse (4 shared papers)Xiaomeng Hu (8 shared papers)Kathy White (6 shared papers)Esteban S. Masuda (7 shared papers)Andrew J. Connolly (3 shared papers)Ying Luo (1 shared paper)Mary Shen (1 shared paper)
Journals: Blood (4 papers)Cancer Research (3 papers)Annals of the Rheumatic Diseases (3 papers)iScience (1 paper)The Journal of Immunology (1 paper)
Partner nations: United States United Kingdom

In The Last Decade

Chi Young

18 papers receiving 272 citations

Peers

Countries citing papers authored by Chi Young

Since Specialization

Citations

This map shows the geographic impact of Chi Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi Young more than expected).

Fields of papers citing papers by Chi Young

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi Young. The network helps show where Chi Young may publish in the future.

Co-authors

The 25 scholars most cited alongside Chi Young, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chi Young Line = papers co-authored together Chi Young links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Rab37 is a novel mast cell specific GTPase localized to secretory granules FEBS Letters ·Esteban S. Masuda, Ying Luo, Chi Young, Mary Shen, Alex B. Rossi, Betty Huang, Sandra Yu, Mark K. Bennett, Don G. Payan, Richard H. Scheller	2000	63
2	Hypoimmune anti-CD19 chimeric antigen receptor T cells provide lasting tumor control in fully immunocompetent allogeneic humanized mice Nature Communications ·Xiaomeng Hu, Karl Manner, Rowena DeJesus, Kathy White, Corie Gattis, Priscilla Ngo, Christopher Bandoro, Eléonore Tham, Elaine Y. Chu, Chi Young, Frank Wells, Ronald Basco, Annabelle M. Friera, Divy Kangeyan, Pascal Beauchesne, William E. Dowdle, T. Deuse, Terry J. Fry, Aaron E. Foster, Sonja Schrepfer	2023	57
3	Human hypoimmune primary pancreatic islets avoid rejection and autoimmunity and alleviate diabetes in allogeneic humanized mice Science Translational Medicine ·Xiaomeng Hu, Corie Gattis, Ari G. Olroyd, Annabelle M. Friera, Kathy White, Chi Young, Ron Basco, Meghan Lamba, Frank Wells, Ramya Ankala, William E. Dowdle, August Lin, Kyla Egenberger, J. Michael Rukstalis, Jeffrey R. Millman, Andrew J. Connolly, T. Deuse, Sonja Schrepfer	2023	55
4	Hypoimmune islets achieve insulin independence after allogeneic transplantation in a fully immunocompetent non-human primate Cell stem cell ·Xiaomeng Hu, Kathy White, Chi Young, Ari G. Olroyd, Paul Kievit, Andrew J. Connolly, T. Deuse, Sonja Schrepfer	2024	29
5	Identification and Characterization of a Myristylated and Palmitylated Serine/Threonine Protein Kinase Biochemical and Biophysical Research Communications ·Amy E. Berson, Chi Young, Sherie L. Morrison, Gregory H. Fujii, Julie Sheung, Bonnie Wu, Joseph B. Bolen, Anne L. Burkhardt	1999	24
6	Hypercalcaemia in sarcoidosis The Lancet ·Chi Young, Robert Burrows, Jonathan L. Katz, H. L. C. Beynon	1999	15
7	Detection of arthritogenic factor in adjuvant arthritis. The Journal of Immunology ·Simon M. Helfgott, Raphael I. Kieval, F. C. Breedveld, Ernest Brahn, Chi Young, Roselynn Dynesius‐Trentham, David E. Trentham	1988	12
8	OP0046 TARGETING IRAK1 AND 4 SIGNALING WITH R835, A NOVEL ORAL SMALL MOLECULE INHIBITOR: A POTENTIAL NEW TREATMENT FOR SYSTEMIC LUPUS ERYTHEMATOSUS Annals of the Rheumatic Diseases ·Chrystelle Lamagna, Meagan Chan, Art Bagos, Ernest Tai, Chi Young, Y. Chen, Li‐Fang Chou, G. Park, Esteban S. Masuda, Vanessa Taylor	2020	5
9	Abstract LB144: Overexpression of CD47 protects hypoimmune CAR T cells from innate immune cell killing Cancer Research ·Xiaomeng Hu, Mo A. Dao, Kathy White, Ryan Clarke, Samuel Landry, Ron Basco, Corie Gattis, Eleonore Tham, Emily Luo, Andrew Tucker, Christopher Bandoro, Elaine Chu, Jun‐Mo Kim, Chi Young, William E. Dowdle, Edward J. Rebar, Terry J. Fry, Sonja Schrepfer	2021	5
10	FRI0016 R835, A NOVEL IRAK1/4 DUAL INHIBITOR IN CLINICAL DEVELOPMENT, BLOCKS TOLL-LIKE RECEPTOR 4 (TLR4) SIGNALING IN HUMAN AND MOUSE Annals of the Rheumatic Diseases ·Chrystelle Lamagna, C. Gundel, Meagan Chan, Chi Young, Sylvia Braselmann, Roy Frances, Sothy Yi, Y. Chen, G. Park, Li‐Fang Chou, Esteban S. Masuda, Vanessa Taylor	2020	4
11	OP0133 PRECLINICAL EFFICACY OF R835, A NOVEL IRAK1/4 DUAL INHIBITOR, IN RODENT MODELS OF JOINT INFLAMMATION Annals of the Rheumatic Diseases ·Chrystelle Lamagna, Meagan Chan, Ernest Tai, Stacey Siu, Roy Frances, Sothy Yi, Chi Young, Vadim Markovtsov, Y. Chen, Li‐Fang Chou, G. Park, Esteban S. Masuda, Vanessa Taylor	2020	4
12	The HIP mouse and all of its organs are completely invisible to allogeneic immune cells iScience ·Xiaomeng Hu, Kathy White, Ari G. Olroyd, Chenyan Wang, Carla Caruso, Corie Gattis, Chi Young, Andrew J. Connolly, T. Deuse, Sonja Schrepfer	2024	3
13	Engineered Hypoimmune Allogeneic CAR T Cells Exhibit Innate and Adaptive Immune Evasion Even after Sensitization in Humanized Mice and Retain Potent Anti-Tumor Activity Blood ·Xiaomeng Hu, Mo A. Dao, Kathy White, Corie Gattis, Ryan Clarke, Samuel Landry, Ron Basco, Eleonore Tham, Andrew Tucker, Emily Luo, Christopher Bandoro, Elaine Chu, Chi Young, Aaron E. Foster, William E. Dowdle, Edward J. Rebar, Terry J. Fry, Sonja Schrepfer	2021	3
14	Abstract 346: Potential role for R191, potent and selective IRAK4 kinase inhibitor, in treatment of hematologic malignancies Cancer Research ·Vadim Markovtsov, Chrystelle Lamagna, Meagan Chan, Sothy Yi, Chi Young, Roy Frances, Stacey Siu, Sylvia Braselmann, Hui Li, Rajinder Singh, Gary Park, Esteban S. Masuda, Vanessa Taylor, Donald G. Payan	2016	3
15	A Dual-Antigen Targeting, Hypoimmune Allogeneic CAR T to Evade Innate and Adaptive Immune Rejection and Overcome Antigen Escape Blood ·Adam Johnson, Hallee Wright, Xiaomeng Hu, Neal Van Hoeven, Brian Granger, Ouwen Liang, Jesus Moreno, Meghan Lamba, Chi Young, Andrew McAlister, Terry J. Fry, Sonja Schrepfer, Aaron E. Foster	2022	2
16	Development of a Novel, Allogeneic GPRC5D-Directed CAR for Treatment of Multiple Myeloma Patients Blood ·Jeremy M. Kinder, Chanel Athena Estrada, Brian Granger, Allison O’Rourke, Ouwen Liang, Aaron Lampano, Garrett Zipp, Vandana Chaturvedi, Xiaomeng Hu, Chi Young, Neal Van Hoeven, Sonja Schrepfer, Terry J. Fry	2023	2
17	R256 Is A Potent And Selective IL-13/4 Receptor Signaling Inhibitor That Reduces Inflammation In A Mouse Model Of Chronic Asthma Vanessa Taylor, Stacey Siu, Chi Young, Linda Ste. Marie, Hong Ren, Thea Leusink-Muis, Ingrid van Ark, Gert Fokerts, Gary Park, Polly Pine, Hui Li, Esteban S. Masuda	2012	2
18	The role of nonsteroidal antiinflammatory drugs in cancer chemoprevention Drugs of the Future ·Chi Young	2004	1
19	Abstract 4869: Small molecule inhibitors of the anti-inflammatory TAM receptor MerTK Cancer Research ·Sacha J. Holland, Alex M. Owyang, Sothy Yi, Chi Young, Sylvia Braselmann, Roy Frances, Arthur Bagos, Ernest Tai, Stacey Siu, Gary Park, David Lau, Matt Duan, Rao Kolluri, Somasekhar Bhamidipati, Ihab S. Darwish, Matthew A. J. Duncton, Rajinder Singh, Esteban S. Masuda, Donald G. Payan	2016	0
20	BCMA-Targeted, Hypoimmune Allogeneic CAR T Cells Exhibit Potent Anti-Tumor Activity Together with the Ability to Evade Innate and Adaptive Immune Rejection in Pre-Clinical Tumor Models Blood ·Jeremy M. Kinder, Chanel Athena-Estrada, Danyal Malik, Xiaomeng Hu, Meghan Lamba, Chi Young, Neal Van Hoeven, Brian Granger, Vandana Chaturvedi, Ouwen Liang, Jesus Moreno, Aaron Lampano, Garrett Zipp, Adam Johnson, Terry J. Fry, Sonja Schrepfer, Aaron E. Foster	2022	0

About Chi Young

Chi Young is a scholar working on Immunology, Oncology, Surgery, Pharmacology and Radiology, Nuclear Medicine and Imaging, having authored 20 papers that have together received 289 indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Phagocytosis and Immune Regulation (3 papers), Immune Cell Function and Interaction (3 papers), Inflammatory mediators and NSAID effects (3 papers), Immune Response and Inflammation (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Pancreatic function and diabetes (2 papers) and Diabetes Management and Research (2 papers). The work is most often cited by research in Immunology (76 citations), Oncology (96 citations), Cell Biology (54 citations), Physiology (14 citations) and Genetics (69 citations). Chi Young has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Sonja Schrepfer, T. Deuse, Xiaomeng Hu, Kathy White, Esteban S. Masuda, Andrew J. Connolly, Ying Luo, Mary Shen, Richard H. Scheller and William E. Dowdle. Their work appears in journals such as Blood, Cancer Research, Annals of the Rheumatic Diseases, iScience and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact